An intravenously administered biologic for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenously administered biologic for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
If you have a Hayes login, click here to view the full report on the Knowledge Center.